These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 21640428)

  • 21. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death.
    Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N
    Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of toxicity of Cleistanthus collinus: vacuolar ATPases are a putative target.
    Kettimuthu KP; Lourthuraj AA; Manickam AS; Subramani S; Ramachandran A
    Clin Toxicol (Phila); 2011 Jul; 49(6):457-63. PubMed ID: 21824057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Archazolid A binds to the equatorial region of the c-ring of the vacuolar H+-ATPase.
    Bockelmann S; Menche D; Rudolph S; Bender T; Grond S; von Zezschwitz P; Muench SP; Wieczorek H; Huss M
    J Biol Chem; 2010 Dec; 285(49):38304-14. PubMed ID: 20884613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and activity of the archazolid western hemisphere.
    Tran AB; Melly GC; Doucette R; Ashcraft B; Sebren LJ; Havko N; Young JC; O'Neil GW
    Org Biomol Chem; 2011 Oct; 9(22):7671-4. PubMed ID: 21931924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of bafilomycin structure to efficiently synthesize solid-state NMR probes that selectively bind to vacuolar-type ATPase.
    Shibata H; Tsuchikawa H; Hayashi T; Matsumori N; Murata M; Usui T
    Chem Asian J; 2015 Apr; 10(4):915-24. PubMed ID: 25605557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
    Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
    J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid.
    Persch E; Basile T; Bockelmann S; Huss M; Wieczorek H; Carlomagno T; Menche D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7735-8. PubMed ID: 23122818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A TGN/EE-Localized V-ATPase Contributes to Vacuolar Acidification.
    Farquharson KL
    Plant Cell; 2015 Dec; 27(12):3292-3. PubMed ID: 26589550
    [No Abstract]   [Full Text] [Related]  

  • 29. What are the roles of V-ATPases in membrane fusion?
    Merz AJ
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):8-9. PubMed ID: 25540413
    [No Abstract]   [Full Text] [Related]  

  • 30. Vacuoles: a hollow threat?
    Yaksh TL
    Can J Anaesth; 2010 Mar; 57(3):195-200. PubMed ID: 20054677
    [No Abstract]   [Full Text] [Related]  

  • 31. Reprogramming of GBM microenvironment by large oncosomes: 'Traveling' V-ATPases are doing more than acidification.
    Garnier D
    EBioMedicine; 2019 Mar; 41():15-16. PubMed ID: 30796004
    [No Abstract]   [Full Text] [Related]  

  • 32. Chloride and the measurement of acid transport.
    Ring T
    Kidney Int; 2012 May; 81(10):1043. PubMed ID: 22543904
    [No Abstract]   [Full Text] [Related]  

  • 33. Bill Harvey retires.
    Knight K; Hoppeler H
    J Exp Biol; 2010 Jan; 213(1):1. PubMed ID: 20008354
    [No Abstract]   [Full Text] [Related]  

  • 34. The glucose signal and metabolic p[H+]lux.
    Rubenstein EM; Schmidt MC
    EMBO J; 2010 Aug; 29(15):2473-4. PubMed ID: 20683466
    [No Abstract]   [Full Text] [Related]  

  • 35. Evolutionary biology: A ratchet for protein complexity.
    Doolittle WF
    Nature; 2012 Jan; 481(7381):270-1. PubMed ID: 22230958
    [No Abstract]   [Full Text] [Related]  

  • 36. The Telluride Symposium on V-ATPases. Proceedings.
    J Exp Biol; 1992 Nov; 172():1-485. PubMed ID: 1362769
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary on some recent theses relevant to combating aging: June 2014.
    Zealley B; de Grey AD
    Rejuvenation Res; 2014 Jun; 17(3):312-7. PubMed ID: 24849189
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical, imaging, morphologic, and molecular features of X-linked VMA21-related myopathy in two unrelated Brazilian families.
    Cotta A; Carvalho E; da-Cunha-Junior AL; Navarro MM; Menezes MM; Paim JF; Valicek J; Lima MI; Velloso-Filho R; Freire-Lyra MH; Takata RI; Inoue M; Okubo M; Iida A; Nishino I
    J Neurol Sci; 2020 Aug; 415():116977. PubMed ID: 32535249
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter to the Editor: Dysosteosclerosis related to the unique mutation in SLC29A3.
    Turan S
    Bone; 2019 Nov; 128():115057. PubMed ID: 31487548
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to "Letter to the editor".
    Kornak U
    Bone; 2019 Nov; 128():115065. PubMed ID: 31561010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.